GE HealthCare Technologies (GEHC) has put molecular imaging in focus after securing CE Mark approval for its MINItrace Magni ...

GE HealthCare Technologies has climbed back in recent weeks after a weak run earlier in the year, which puts fresh focus on ...

GE HealthCare Technologies Inc. closed 21.63% below its 52-week high of $89.77, which the company reached on January 8th. Supported by world-class markets data from Dow Jones and FactSet, and ...

The deal expands GE HealthCare’s footprint in radiopharmaceuticals, its fastest-growing segment.

GE HealthCare claimed European approval for a compact cyclotron designed for the local production of rapidly decaying PET ...

Over the last six months, GE HealthCare’s shares have sunk to $68.00, producing a disappointing 7.9% loss - a stark contrast ...

GE HealthCare's MINItrace Magni achieves CE Mark; Copper-64 expands PETtrace Solid Target Platform beyond Gallium-68: Chicago Saturday, October 17, 2026, 11:00 Hrs [IST] GE Health ...

Oct 5 (Reuters) - Medical device maker GE HealthCare said on Monday it would buy privately held Sofie Biosciences for $945 million in cash, in a move that strengthens its ability to manufacture and ...

The goal is to obtain last-mile logistics for radioactive agents with a short half-life that need to be made as close to patients as possible.

The purchase expands GE HealthCare’s radiopharmaceutical capabilities, helping manufacture and distribute time-sensitive ...

GE HealthCare on Thursday announced it is working with Amazon Web Services to build new generative AI models and applications that are specialized for medical use cases. The health-care industry is ...

- Queen’s and a nationally recognized academic medical center to provide clinical expertise to enhance GE HealthCare’s forthcoming software solution - New software solution will use AI and predictive ...